Pharmacology, Toxicology and Pharmaceutical Science
Syndrome
100%
Coronavirinae
100%
Cytokine Storm
100%
Tocilizumab
100%
Diseases
100%
Interleukin 6
50%
Receptor
33%
Adult Respiratory Distress Syndrome
33%
Multiple Organ Failure
33%
Randomized Controlled Trial
16%
Monoclonal Antibody
16%
SARS Coronavirus
16%
Hyperferritinemia
16%
Keyphrases
COVID-19
100%
Tocilizumab
100%
Cytokine Storm Syndrome
100%
Acute Respiratory Distress Syndrome
33%
Severe Cases
33%
Multiple Organ Failure
33%
IL-6 Receptor
33%
Monoclonal Antibody
16%
Randomized Controlled Trial
16%
Adverse Effects
16%
Clinical Characteristics
16%
Young Males
16%
Male Patients
16%
Close Monitoring
16%
Number of Subjects
16%
Clinical Manifestations
16%
Transmission Rate
16%
IL-6 Level
16%
Hyperferritinemia
16%
Medicine and Dentistry
Coronavirinae
100%
Cytokine Storm
100%
Tocilizumab
100%
Diseases
100%
Interleukin 6
50%
Receptor
33%
Acute Respiratory Distress Syndrome
33%
Multiple Organ Dysfunction Syndrome
33%
Monoclonal Antibody
16%
Randomized Controlled Trial
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Hyperferritinemia
16%
Adverse Effect
16%